Research at Barts Health
First patient worldwide recruited to next stage of trial for bleeding disorder
The team at Royal London’s Haemophilia Centre has recruited the first patient in the world to the next stage of a clinical trial for Von Willebrand disease, the most common inherited bleeding disorder.
New hope for breast cancer patients as drug receives NHS approval in England
Thousands of patients living with an incurable form of breast cancer will now be able to get a life-extending treatment on the NHS in England, following clinical trials carried out at Barts Health.
Patients join national trial for heart valve surgery
Barts Health is taking part in a national clinical trial working to identify the safest and most effective blood-thinning treatment for patients recovering from heart valve surgery.
Body fat distribution as important as BMI in predicting future health risks, new study suggests
Researchers have found that how fat accumulates in the body is just as important for identifying different health risks as a person’s overall weight.
Barts Health tops chart for commercial trial recruitment
More patients from our hospitals are directly benefitting from new drugs and devices, whilst helping ensure they are safe and effective for other patients in the future, than in any other NHS trust in the country.